200 results
Page 5 of 10
8-K
EX-99.1
yr2ravx
22 Jul 22
Entry into a Material Definitive Agreement
8:35am
8-K
EX-10.1
ak9dn
22 Jul 22
Entry into a Material Definitive Agreement
8:35am
424B3
re24 ryg2j
22 Jul 22
Prospectus supplement
8:30am
8-K
EX-10.1
btyhhp797qxzuwzbu
18 Jul 22
Ra Medical Systems Appoints Brian D. Conn Interim Chief Financial Officer
4:15pm
POS AM
ndd 4lonhc
13 Jul 22
Prospectus update (post-effective amendment)
6:13am
8-K
EX-99.1
9l6yay51 1iwvll1ws
8 Jul 22
Ra Medical Systems Receives FDA 510(k) Clearance for the DABRA 2.0 Catheter
4:23pm
8-K
53banmc7jt7vj2
6 Jun 22
Cost Associated with Exit or Disposal Activities
4:36pm
8-K
EX-99.1
oedg5epgk5a4jg1s
16 May 22
Ra Medical Systems Reports First Quarter 2022 Financial Results
4:28pm
8-K
EX-99.1
v0rwbf wm9jpamg73
23 Mar 22
Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results
4:21pm
8-K
EX-1.1
2m34t3udn1j66adzzgjq
9 Feb 22
Ra Medical Systems, Inc. Announces Pricing of $12.0 Million Underwritten Public Offering
12:00am
8-K
EX-4.4
opfx 4t60
9 Feb 22
Ra Medical Systems, Inc. Announces Pricing of $12.0 Million Underwritten Public Offering
12:00am
424B1
ud8k47
7 Feb 22
Prospectus with pricing info
6:02am
FWP
j43ad81ov5bvz4so
28 Jan 22
Free writing prospectus
6:03am